Related Experiment Videos
Spacer-induced atrial fibrillation
1Saint Michael's Medical Center, Newark, NJ 07102.
New Jersey Medicine : the Journal of the Medical Society of New Jersey
|February 1, 1990
Summary
Inhaled sympathomimetics, commonly used for asthma, are generally safe. However, a case report shows albuterol with a spacer may induce atrial fibrillation.
Area of Science:
- Pulmonology
- Cardiology
- Pharmacology
Background:
- Inhaled sympathomimetics are primary treatments for asthma.
- Extensive research suggests these medications are safe regarding cardiac arrhythmias.
Observation:
- A case report details a patient experiencing atrial fibrillation.
- This event occurred after the administration of albuterol via a spacer device.
Findings:
- Albuterol, a common inhaled sympathomimetic, can potentially trigger atrial fibrillation.
- The use of a spacer device may be a factor in this adverse cardiac event.
Implications:
- Clinicians should be aware of potential cardiac risks associated with inhaled albuterol, even when used with a spacer.
- Further investigation into sympathomimetic-induced arrhythmias is warranted.